{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T08:28:33Z","timestamp":1772612913000,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ejphar.2016.02.001","type":"journal-article","created":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T08:17:03Z","timestamp":1454401023000},"page":"55-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Novel sulfamides and sulfamates derived from amino esters: Synthetic studies and anticonvulsant activity"],"prefix":"10.1016","volume":"774","author":[{"given":"Maria L.","family":"Villalba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea V.","family":"Enrique","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josefina","family":"Higgs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo A.","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sof\u00eda","family":"Goicoechea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Facundo D.","family":"Taborda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana","family":"Gavernet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ileana D","family":"Lick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariel","family":"Marder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis E.","family":"Bruno Blanch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2016.02.001_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.eplepsyres.2012.10.001","article-title":"Progress report on new antiepileptic drugs: a summary of the Eight Eilat Conference (EILAT XI)","volume":"103","author":"Bialer","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2016.02.001_bib2","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1021\/jo01314a033","article-title":"Sulfonylamine-mediated sulfamation of amines. A mild, high yield synthesis of sulfamic acid salts","volume":"45","author":"DuBois","year":"1980","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejphar.2016.02.001_bib3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jps.3030460322","article-title":"A note on a simple apparatus for detecting neurological deficit in rats and mice","volume":"46","author":"Dunham","year":"1957","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.ejphar.2016.02.001_bib4","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"A practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2016.02.001_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2007.00992.x","article-title":"Refractory epilepsy: clinical overview","volume":"48","author":"French","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2016.02.001_bib6","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1016\/j.bmc.2007.05.024","article-title":"Design, synthesis and anticonvulsant activity of some sulfamides","volume":"15","author":"Gavernet","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2016.02.001_bib7","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.bmc.2006.06.010","article-title":"3D QSAR design of novel antiepileptic sulfamides","volume":"15","author":"Gavernet","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2016.02.001_bib8","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1021\/jm800764p","article-title":"Synthesis and anticonvulsant activity of amino acid-derived sulfamides","volume":"52","author":"Gavernet","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2016.02.001_bib9","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.bmc.2012.10.048","article-title":"Inhibition pattern of sulfamide-related compounds in binding to carbonic anhydrase isoforms I, II, VII, XII and XIV","volume":"21","author":"Gavernet","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2016.02.001_bib10","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1046\/j.1528-1157.2001.042007831.x","article-title":"Anticonvulsant profile of valrocemide (TV1901): a new antiepileptic drug","volume":"42","author":"Isoherranen","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2016.02.001_bib11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1528-1157.1978.tb04507.x","article-title":"Antiepileptic drug development: II. Anticonvulsant drug screening","volume":"19","author":"Krall","year":"1978","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2016.02.001_bib12","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jenvman.2008.09.003","article-title":"Adsorption of phenol and its derivatives from water using synthetic resins and low-cost natural adsorbents: a review","volume":"90","author":"Lin","year":"2009","journal-title":"J. Environ. Manag."},{"key":"10.1016\/j.ejphar.2016.02.001_bib13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0920-1211(91)90062-K","article-title":"The role of technical, biological and pharmacological factor in the laboratory evaluation of anticonvulsant drugs. III. Pentilenetetrazole seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2016.02.001_bib14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1528-1167.2011.03024.x","article-title":"Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma","volume":"52","author":"L\u00f6scher","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2016.02.001_bib15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bmc.2003.10.036","article-title":"Investigation into new anticonvulsant derivatives of R-substituted N-benzylamides of \u03b3-hydroxy- and \u03b3-acetoxybutyric acid. Part 5: search for new anticonvulsant compounds","volume":"12","author":"Malawska","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2016.02.001_bib16","doi-asserted-by":"crossref","first-page":"9019","DOI":"10.1021\/jm400894u","article-title":"Novel, broad-spectrum anticonvulsants containing a sulfamide group: pharmacological properties of (S)-N-[(6-Chloro-2,3-dihydrobenzo[1,4]dioxin-2-yl)methyl]sulfamide (JNJ-26489112)","volume":"56","author":"McComsey","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2016.02.001_bib17","series-title":"Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications","first-page":"291","article-title":"Carbonic Anhydrase Inhibitors Drug Design","author":"McKenna","year":"2014"},{"key":"10.1016\/j.ejphar.2016.02.001_bib18","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0140-6736(14)60456-6","article-title":"Epilepsy: new advances","volume":"385","author":"Mosh\u00e9","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2016.02.001_bib19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2174\/1568011054866955","article-title":"Steroid sulfatase inhibitors: their potential in the therapy of breast cancer","volume":"5","author":"Nussbaumer","year":"2005","journal-title":"Curr. Med. Chem. - Anti-Cancer Agents"},{"key":"10.1016\/j.ejphar.2016.02.001_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3949\/ccjm.51.2.293","article-title":"Antiepileptic drug development program","volume":"51","author":"Porter","year":"1984","journal-title":"Cleve Clin. Q."},{"key":"10.1016\/j.ejphar.2016.02.001_bib21","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1517\/13543770903185920","article-title":"The role of sulfamide derivatives in medicinal chemistry: a patent review (2006\u20132008)","volume":"19","author":"Reitz","year":"2009","journal-title":"Expert Opin. Ther. Patents"},{"key":"10.1016\/j.ejphar.2016.02.001_bib23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bcp.2011.10.015","article-title":"N,N\u2032-Dicyclohexylsulfamide and N,N\u2032-diphenethylsulfamide are anticonvulsant sulfamides with affinity for the benzodiazepine binding site of the GABAAreceptor and anxiolytic activity in mice","volume":"83","author":"Wasowski","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.02.001_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1517\/13543776.16.1.27","article-title":"The sulfamide motif in the design of enzyme inhibitors","volume":"16","author":"Winum","year":"2006","journal-title":"Expert Opin. Ther. Patents"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916300164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916300164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T20:25:42Z","timestamp":1537043142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299916300164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":23,"alternative-id":["S0014299916300164"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.02.001","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel sulfamides and sulfamates derived from amino esters: Synthetic studies and anticonvulsant activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}